Mesa Labs Inc MLAB

$129.87 +1.21 (0.94%)

Valuation

Market cap
719,969,000
Revenue TTM
$249,130,000
Net income TTM
$6,710,000
PE ratio
17.40
Forward PE
—
Profit margin
2.69%
Debt to equity
0.76

Trading

Volume
52,400
Avg volume
123,418
Day's range
$128.87 – $131.19
Shares out
5,596,000
Stochastic %K
85%
Beta
1.06
Analysts
Sell
Price target
$125.00

Price

Company profile

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the...

Show more

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Industry
Scientific & Technical Instruments
Sector
Technology
Phone
303 987 8000
Website
https://www.mesalabs.com
Address
12100 West Sixth Avenue, Lakewood, United States

Latest news

Stocktwits

Tickrtrends Oct 21, 6:15 PM
$MLAB screens as undervalued on TickrTrends. It changed from fairly valued to undervalued in this week's run. Mesa Laboratories lists Gross margin 64.9% alongside P/E trailing 15x. Informational screening only, not investment advice. Do your own research. https://stocks.tickrtrends.com/mlab?utm_source=stocktwits&utm_medium=social&utm_campaign=verdict-change
0 replies
filecrux Oct 13, 12:17 PM
$MLAB Mesa Labs, maker of quality-control tools for drug and device makers, says its restructuring will cut Clinical Genomics revenue as it drops that unit's lowest-margin accounts, with ~40 jobs (~6% of staff) going. CG was $10.3M, 17% of sales, in the quarter to June 30, 2026; the size of the drop isn't given. In return: $9.3M of annual cost cuts, $5.0M net after $4.3M reinvested, fully in place by end of FY28, plus a higher CG gross margin; cash cost $2.9M-$3.7M. FY27 guidance comes with Q2 results Nov 9, 2026.
0 replies
NVDAMillionaire Sep 24, 10:30 AM
$MLAB Excellent article that nails exactly where MLAB stands right now. So if you want to update your MLAB knowledge or get acquainted with MLAB, this is a must read. https://everyticker.com/quote/MLAB/analysis/execution-repair-meets-portfolio-focus-at-mesa-laboratories-nasdaq-mlab
0 replies
Doozio Aug 19, 11:26 PM
$MLAB chop chop huckleberries Roger!
0 replies
CEOBuysDisclosures Aug 17, 5:55 PM
$MLAB CEO purchased 7,093 shares at $112.80 for a total of $800,090. Kadia Siddhartha now owns 7,093 shares. https://ceo-buys.com
0 replies
FilingTracker Aug 17, 3:51 PM
$MLAB CEO opened new $800K position: https://filingtracker.ai/filing/724004/0000724004-26-000084?doc=primary_doc.xml
0 replies
FilingTracker Aug 17, 3:28 PM
$MLAB Insider purchase: https://filingtracker.ai/filing/724004/0000724004-26-000083?doc=primary_doc.xml
0 replies
StocktwitsEarnings Aug 10, 8:09 PM
$MLAB Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $0.50 down -42.53% YoY • Reported revenue of $60.14M up 1.00% YoY
0 replies